Page last updated: 2024-11-08

isophorone diisocyanate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID169132
CHEMBL ID1509442
CHEBI ID53214
SCHEMBL ID15846
MeSH IDM0064461

Synonyms (72)

Synonym
isophorone diisocyanate ,
NCGC00091745-01
4098-71-9
isophorone diisocyanate [diisocyanates]
ccris 6252
ipdi
brn 2726467
einecs 223-861-6
3-isocyanatomethyl-3,5,5-trimethylcyclohexylisocyanate
isophorone diamine diisocyanate
isocyanic acid, methylene(3,5,5-trimethyl-3,1-cyclohexylene) ester
un2290
3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate
hsdb 6337
isophorone diisocyanate, 98%
NCGC00091745-02
cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-
5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane
CHEBI:53214 ,
I0314
AKOS000120330
NCGC00091745-03
NCGC00091745-04
dtxsid0023826 ,
tox21_201520
NCGC00259070-01
dtxcid903826
tox21_300298
NCGC00254143-01
cas-4098-71-9
5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-cyclohexane
A825377
43b0856528 ,
isophorone diisocyanate [un2290] [poison]
ec 223-861-6
unii-43b0856528
methylene(3,5,5-trimethyl-3,1-cyclohexylene) ester
EPITOPE ID:113238
isophorone diisocyanate, (+/-)-
(+/-)-isophorone diisocyanate
isophorone diisocyanate [inci]
3,3,5-trimethyl-5-(isocyanatomethyl)cyclohexyl isocyanate
1-isocyanato-3-(isocyanatomethyl)-3,5,5-trimethylcyclohexane
1-isocyanato-3,3,5-trimethyl-5-(isocyanatomethyl)cyclohexane
1-isocyanato-3-isocyanatomethyl-3,5,5-trimethylcyclohexane
1-(isocyanatomethyl)-5-isocyanato-1,3,3-trimethylcyclohexane
isophorone diisocyanate [hsdb]
isophorone diisocyanate (ipdi)
1,3,3-trimethyl-1-(isocyanatomethyl)-5-isocyanatocyclohexane
3-isocyanatomethyl-3,5,5- trimethylcyclohexyl isocyanate
SCHEMBL15846
1-isocyanato-3,3,5-trimethyl-5-isocyanatomethylcyclohexane
1-isocyanato-3,3,5-trimethyl-5-isocyanatomethyl cyclohexane
1-isocyanato-3,3,5-trimethyl-5-isocyanato methyl cyclohexane
5-isocyanato-1-isocyanatomethyl-1,3,3-trimethylcyclohexane
1-iso cyanato-3,3,5-trimethyl-5-isocyanatomethyl cyclohexane
1-isocyanato-3-isocyanatomethyl-3,5,5-trimethyl cyclohexane
un 2290
1,1,5,5-tetramethylcyclohexane-.alpha.',3-diisocyanate
3-(isocyanatomethyl)-3,5,5-trimethylcyclohexyl isocyanate
vestanat ipdi
isocyanic acid, diester with 5-hydroxy-1,3,3-trimethylcyclohexanemethanol
1-isocyanato-5-(isocyanatomethyl)-3,3,5-trimethylcyclohexane
CHEMBL1509442
mfcd00064956
F2191-0302
Q415415
?isophorone diisocyanate
EN300-20558
5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl cyclohexane
triisocyanatoisocyanurate, solution, 70% by weight
3-isocyanatomethyl-3,5,5-trimethylcyclohexyl-isocyanate

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
diisocyanateAn isocyanate compound containing two isocyanate functional groups. Manufactured for reaction with polyols in the production of polyurethanes.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (24)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency30.82300.000221.22318,912.5098AID588515; AID743035
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency50.11870.001024.504861.6448AID588535
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency21.87240.001019.414170.9645AID743094
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency55.69470.023723.228263.5986AID743222
activating transcription factor 6Homo sapiens (human)Potency55.69470.143427.612159.8106AID1159516
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency25.11890.031610.279239.8107AID884; AID885
lethal factor (plasmid)Bacillus anthracis str. A2012Potency31.62280.020010.786931.6228AID912
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency25.11891.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (4.65)18.7374
1990's5 (11.63)18.2507
2000's11 (25.58)29.6817
2010's18 (41.86)24.3611
2020's7 (16.28)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.83 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index81.12 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (4.55%)4.05%
Observational0 (0.00%)0.25%
Other42 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]